Azzad Asset Management’s Pediatrix Medical MD Stock Holding History

Azzad Asset Management’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-14,320	Closed	-$994K	–	302
2017 Q1	$994K	Hold	14,320	–	–	0.37%	104
2016 Q4	$955K	Hold	14,320	–	–	0.39%	90
2016 Q3	$949K	Hold	14,320	–	–	0.39%	96
2016 Q2	$1.04M	Hold	14,320	–	–	0.44%	77
2016 Q1	$925K	Hold	14,320	–	–	0.4%	97
2015 Q4	$1.03M	Hold	14,320	–	–	0.49%	79
2015 Q3	$1.1M	Hold	14,320	–	–	0.58%	54
2015 Q2	$1.06M	Hold	14,320	–	–	0.54%	60
2015 Q1	$1.04M	Hold	14,320	–	–	0.5%	65
2014 Q4	$947K	Hold	14,320	–	–	0.5%	60
2014 Q3	$785K	Hold	14,320	–	–	0.45%	73
2014 Q2	$833K	Buy	14,320 +3,581	+33%	+$211K	0.5%	67
2014 Q1	$660K	Buy	+10,739	New	+$625K	0.44%	85

Other funds holding MD

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

TSW

Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Azzad Asset Management's MD Position: Q2 2017 in Review

Azzad Asset Management sold out of Pediatrix Medical (MD) in Q2 2017, closing a stake of 14,320 shares — an estimated $994K sold.

Azzad Asset Management first reported a position in MD in Q1 2014 and held it in 13 quarters. The position peaked at $1.1M in Q3 2015. 332 funds tracked by Wall St. Rank hold MD as of Q2 2017.

Azzad Asset Management reported no remaining Pediatrix Medical position as of Q2 2017 after selling out during the quarter.
Azzad Asset Management sold 14,320 Pediatrix Medical shares in Q2 2017, an estimated $994K.
Azzad Asset Management first reported a position in Pediatrix Medical in Q1 2014 and held it in 13 quarters.
Azzad Asset Management's Pediatrix Medical position peaked at $1.1M in Q3 2015.
332 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2017.

Based on Azzad Asset Management's 13F filing for Q2 2017, filed 3 Apr 2024.